Stock Research: Medical Developments International

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Medical Developments International

ASX:MVP AU000000MVP2
12
  • Value
    51
  • Growth
    11
  • Safety
    Safety
    62
  • Combined
    28
  • Sentiment
    25
  • 360° View
    360° View
    12
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medical Developments International Limited delivers emergency medical solutions. It operates in Pain Management (Penthrox inhaled analgesic) and Respiratory (asthma/COPD products). The company serves Australia, the United States, Europe, and Asia. In the last fiscal year, the company had a market cap of $43 million, profits of $16 million, and revenue of $22 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 36 42 17
Growth
11 43 25 39
Safety
Safety
62 21 47 45
Sentiment
25 34 30 50
360° View
360° View
12 13 14 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
37 62 62 87
Opinions Change
50 50 50 50
Pro Holdings
n/a 14 4 8
Market Pulse
34 59 48 51
Sentiment
25 34 30 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
51 36 42 17
Growth
11 43 25 39
Safety Safety
62 21 47 45
Combined
28 10 23 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
81 44 66 13
Price vs. Earnings (P/E)
1 75 75 36
Price vs. Book (P/B)
100 81 73 23
Dividend Yield
1 1 1 1
Value
51 36 42 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
86 48 95 85
Profit Growth
24 100 23 1
Capital Growth
1 1 29 78
Stock Returns
5 30 3 19
Growth
11 43 25 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
71 70 73 68
Refinancing
86 36 77 37
Liquidity
13 1 1 43
Safety Safety
62 21 47 45

Similar Stocks

Discover high‑ranked alternatives to Medical Developments International and broaden your portfolio horizons.

Nippon Shinyaku

TYO:4516
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

Towa Pharmaceutical

TYO:4553
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Regis Resources

ASX:RRL
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

The only above-average rank is Safety. All other ranks (Value, Growth, and Sentiment) are below average. As Safety is the least critical rank, there are few positive facts to support this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: